Article
Adenosine 5'monophosphate-activated protein kinase activation reduces the risks of psoriasis and its comorbidities: a Mendelian randomization study in the UK Biobank.
Rheumatology (Oxford, England) - 3 May 2024
Xiao Yi, Jing Danrong, Zhou Guowei, Tang Zhenwei, Peng Cong, Kuang Yehong, Zhu Wu, Chen Xiang, Liu Hong, Shen Minxue
Abstract excerpt
OBJECTIVE: Whether metformin and its adenosine 5'monophosphate-activated protein kinase (AMPK) activation protect from psoriasis risk is unconcluded. We investigated the effect of AMPK, a pharmacological target of metformin, on the risk of psoriasis and its comorbidities and mortality among participants in the UK Biobank (UKB). METHODS: To avoid immortal time biases in pharmacoepidemiologic studies, Mendelian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
